ABFL - ETF AI Analysis

Top Page

Fcf Us Quality Etf (ABFL)

Rating:73Outperform

Price Target:―

ABFL, the Fcf Us Quality ETF, earns a solid overall rating largely because many of its biggest positions—like Apple, Nvidia, Lam Research, and Vertiv—combine strong financial performance with growth opportunities in areas such as AI, data centers, and services. Healthcare leaders like Bristol-Myers Squibb and Amgen also support the fund with solid earnings and strategic pipelines, though issues like high valuations, debt levels, and some weaker names such as Colgate-Palmolive with leverage and operational challenges slightly weigh on the rating. The main risk is that several key holdings share similar concerns around high valuations and leverage, which could hurt the ETF if market conditions turn against these types of stocks.

Positive Factors

Growing Asset Base

The fund manages a sizable pool of money, which suggests it has attracted meaningful investor interest and liquidity.

Balanced Sector Mix

Holdings are spread across technology, health care, consumer, industrial, and other sectors, helping reduce the impact of weakness in any single industry.

Several Strong Recent Performers

Some top positions, such as Lam Research, Tapestry, Colgate-Palmolive, and Vertiv, have shown strong recent performance, supporting the fund’s overall results.

Negative Factors

Moderately High Expense Ratio

The fund’s fee is on the higher side for an ETF, which can slowly eat into long-term returns compared with lower-cost options.

Heavy U.S. Concentration

Almost all assets are invested in U.S. companies, offering little geographic diversification if the U.S. market struggles.

Recent Weakness in Key Tech and Mega-Cap Names

Important holdings like Nvidia, Apple, AbbVie, and Mastercard have shown weak recent performance, which has weighed on the fund’s short-term returns.

ABFL vs. SPDR S&P 500 ETF (SPY)

AUM661.57M

RegionNorth America

Expense Ratio0.49%

Beta1.00

IssuerAbacus

Inception DateSep 27, 2016

Dividend Yield0.62%

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume227,416

30 Day Avg. Volume70,278

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

87.70

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering61

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

ABFL Summary

ABFL is the FCF US Quality ETF, which invests in a wide range of U.S. companies but focuses on businesses with strong finances and steady cash flow. It doesn’t track a traditional index, but follows a “quality” theme across the total U.S. market, from large to smaller companies. Top holdings include well-known names like Nvidia and Apple. Someone might invest in ABFL to get diversified exposure to many U.S. stocks while tilting toward financially solid companies that may offer long-term growth. A key risk is that it is heavily weighted toward technology stocks, so its price can swing with the tech sector and overall market.

How much will it cost me?The Fcf US Quality ETF (ABFL) has an expense ratio of 0.49%, meaning you’ll pay $4.90 per year for every $1,000 invested. This is slightly higher than average because it is actively managed, focusing on selecting quality stocks with strong financial health and sustainable cash flow.

What would affect this ETF?The ABFL ETF, with its strong focus on U.S. quality stocks and significant exposure to technology, could benefit from continued innovation and growth in the tech sector, as well as stable economic conditions that support consumer spending and healthcare advancements. However, it may face challenges from rising interest rates, which can negatively impact growth-oriented sectors like technology and consumer cyclical, or from regulatory changes targeting large-cap tech companies. Its diversified holdings help mitigate risks, but sector-specific volatility remains a key factor to watch.

ABFL Top 10 Holdings

ABFL is leaning heavily into U.S. tech and health care, with Nvidia and Lam Research helping to power the fund thanks to their steady climb on the back of AI and chip demand. Vertiv has been a real spark plug, surging recently and adding extra juice to performance. On the flip side, Apple looks a bit tired, with mixed momentum that keeps it from pulling its usual weight, while AbbVie has been more of a drag. A trio of steadier pharma names like Amgen, Bristol-Myers, and Gilead helps smooth out the ride.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
NVDA	Nvidia	4.66%	$30.82M	$4.46T	57.80%	76 Outperform
AAPL	Apple	4.51%	$29.86M	$3.82T	7.69%	79 Outperform
VRT	Vertiv Holdings	3.31%	$21.89M	$95.55B	184.31%	77 Outperform
ABBV	AbbVie	3.02%	$19.99M	$410.83B	7.38%	66 Neutral
TPR	Tapestry	2.99%	$19.80M	$30.29B	99.68%	69 Neutral
BMY	Bristol-Myers Squibb	2.99%	$19.75M	$123.70B	-1.31%	78 Outperform
AMGN	Amgen	2.95%	$19.50M	$198.16B	13.75%	77 Outperform
LRCX	Lam Research	2.87%	$18.99M	$268.09B	152.28%	77 Outperform
MA	Mastercard	2.74%	$18.12M	$467.90B	-4.47%	75 Outperform
CL	Colgate-Palmolive	2.70%	$17.88M	$74.28B	-3.29%	63 Neutral

ABFL Technical Analysis

Technical Analysis Sentiment

Negative

Last Price―

Price Trends

50DMA

72.88

Negative

100DMA

72.13

Negative

200DMA

71.07

Positive

Market Momentum

MACD

>-0.01

Positive

RSI

42.68

Neutral

STOCH

46.46

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ABFL, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 73.33, equal to the 50-day MA of 72.88, and equal to the 200-day MA of 71.07, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 42.68 is Neutral, neither overbought nor oversold. The STOCH value of 46.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ABFL.

ABFL Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
ABFL	―	―	$661.57M	0.49%	73 Outperform
ULTY	―	―	$953.40M	1.30%	60 Neutral
SYLD	―	―	$922.43M	0.59%	69 Neutral
BGDV	―	―	$753.48M	0.45%	74 Outperform
XCHG	―	―	$652.82M	0.50%	68 Neutral
EBI	―	―	$613.01M	0.24%	68 Neutral

Performance Comparison

ABFL

Fcf Us Quality Etf

71.78

8.17

12.84%

ULTY

YieldMax Ultra Option Income Strategy ETF

―

SYLD

Cambria Shareholder Yield ETF

―

BGDV

Bahl & Gaynor Dividend ETF

―

XCHG

AB US Equity ETF

―

EBI

Longview Advantage ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents